Mostrando 4 resultados de: 4
Filtros aplicados
Subtipo de publicación
Article(4)
Área temáticas
Fisiología humana(3)
Enfermedades(2)
Farmacología y terapéutica(2)
Bioquímica(1)
Fisiología y materias afines(1)
Origen
scopus(4)
Dose-response effects of PEGylated cholecystokinin on the behavioral satiety sequence
ArticleAbstract: Cholecystokinin (CCK) is known to have a short biological half-life. In order to prolong the half-liPalabras claves:AVERSIÓN, Behavioral satiety sequence, dose-response, PEGylated Cholecystokinin, SatietyAutores:Buyse J., Cokelaere M., De Buyser K., Decuypere E., Fabián León-Tamariz, Pottel H., Verbaeys I.Fuentes:scopusLack of tolerance development with long-term administration of PEGylated cholecystokinin
ArticleAbstract: Cholecystokinin (CCK) is a short acting satiating peptide hormone produced in the proximal small intPalabras claves:Cholecystokinin, Long-term administration, Pancreas proliferation, PEGylated Cholecystokinin, Satiety, toleranceAutores:Buyse J., Cokelaere M., Decuypere E., Fabián León-Tamariz, Pottel H., Verbaeys I.Fuentes:scopusPEGylated cholecystokinin is more potent in inducing anorexia than conditioned taste aversion in rats
ArticleAbstract: Background and purpose: The physiological involvement of endogenous cholecystokinin (CCK) in the terPalabras claves:2-NAP, Cholecystokinin, Conditioned taste aversion, Devazepide, Malaise, PEGylated Cholecystokinin, SatietyAutores:Cokelaere M., Decuypere E., Fabián León-Tamariz, Pottel H., Swennen Q., Verbaeys I.Fuentes:scopusPEGylated cholecystokinin prolongs satiation in rats: Dose dependency and receptor involvement
ArticleAbstract: Background and purpose: Acute intraperitoneal (i.p.) administration of cholecystokinin (CCK) is knowPalabras claves:Anorexia, CCK receptor antagonists 1, Cholecystokinin, Devazepide 2-NAP, dose-response, PEGylated CholecystokininAutores:Buyse J., Cokelaere M., De Cuyper M., Fabián León-Tamariz, Pottel H., van Boven M., Verbaeys I.Fuentes:scopus